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ABSTRACT 
Introduction: Agave brittoniana Trel species. subsp. brachypus is characterized by its high content of ste-
roidal saponins and these metabolites have anti-inflammatory properties. However, no previous studies 
indicate that extracts rich in saponins from this species have anti-inflammatory effect in vivo models.
Method: Steroidal saponins in n-butanolic extract were obtained from a hydroalcoholic extract of Agave 
brittoniana. Phytochemical studies were used to verify the saponins presence. Doses of 25, 50 and 100 
mg/kg were used in the acute model of edema induced by carrageenan and in the chronic model of cot-
ton pellet-induced granuloma. Five groups of six male Sprague-Dawley rats each were designed by each 
in vivo study: three groups for saponin-enriched fraction at different doses, a normal control group and 
a positive control, which was treated with indomethacin. The inhibition percentage of the inflammatory 
reaction was the major answer variable.
Results: The acute model of carrageenan-induced rat paw edema indicated that the groups correspond-
ing to the doses of 50 and 100 mg/kg of saponin-enriched fraction showed the highest percentages of 
inhibition, after three hours of treatment. According to the chronic model results, saponins-enriched 
butanolic extract showed anti-inflammatory activity by reducing the dry weight of the granuloma and 
increasing the inhibition percentage.
Conclusions: Saponin-enriched fraction from Agave brittoniana T. subsp. brachypus, have an anti-inflam-
matory effect in acute and chronic experimental models. 
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RESUMEN
Introducción: La especie Agave brittoniana Trel. subsp. brachypus se caracteriza por su alto contenido de 
saponinas esteroidales y estos metabolitos presentan propiedades antiinflamatorias. Sin embargo, nin-
gún estudio previo señala que extractos ricos en saponinas de esta especie tienen efecto antiinflamatorio 
en modelos in vivo.
Método: Saponinas esteroidales extraídas en n-butanólico fueron obtenidas a partir de un extracto hi-
droalcohólico de Agave brittoniana. Estudios fitoquímicos se usaron para corroborar la presencia de sapo-
ninas. Dosis de 25, 50 y 100 mg/kg fueron usadas en el modelo agudo de edema inducido por carrage-
nina y en el modelo crónico de granuloma inducido por pellet de algodón. Se diseñaron cinco grupos de 
seis ratas machos Sprague-Dawley cada uno: tres grupos para la fracción enriquecida de saponinas a las 
diferentes dosis, un grupo control normal y un control positivo, el cual fue tratado con indometacina. El 
porcentaje de inhibición de la reacción inflamatoria fue la principal variable respuesta.
Resultados: El modelo agudo de edema plantar inducido por carragenina reveló que las dosis de 50 y 
100 mg/kg de la fracción enriquecida de saponinas mostraron los mayores porcentajes de inhibición, 
después de tres horas de tratamiento. Según los resultados del modelo crónico, el extracto butanólico 
enriquecido con saponinas mostró actividad antiinflamatoria por reducción del peso seco del granuloma 
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Conclusiones: La fracción enriquecida de saponinas de 
Agave brittoniana T. subsp. brachypus, tiene un efecto antiin-
flammatorio en modelos experimentales agudo y crónico.
Palabras clave: saponinas; Agave; antiinflamatorio; carra-
genina; granuloma
INTRODUCTION
The factors involved in the inflammatory process are pres-
ent in many pathologies. The search of anti-inflammatory 
agents is one of the most addressed fields in the research 
of new therapeutic targets(1,2). Although there is a consid-
erable therapeutic arsenal of anti-inflammatory synthetic 
drugs, the high incidence of adverse events has determined 
a lasting searching for drugs of natural origin with similar 
pharmacological effectiveness and low toxicity index(3).
Saponins are secondary metabolites from numerous spe-
cies with structural similarity to steroidal anti-inflamma-
tory drugs(4-7). Agave brittoniana subsp. brachypus (Trel.) A. 
Álvarez, (Asparagaceae) endemic specie to the Cuban cen-
tral region and belonging to the genus Agave(8), is charac-
terized by its high content of steroidal saponins. Studies in 
different biological systems have shown the anti-inflam-
matory activity of several species of the genus Agave(9). 
Agave sisalana Perrine showed an anti-inflammatory ef-
fect in carrageenan-induced rat paw edema and cotton 
pellet-induced granuloma(10). An anti-inflammatory effect 
has been reported from Agave angustifolia on croton oil-in-
duce ear edema in mice.(11). There is a study of da Silva and 
Parente about Agave brittoniana specie from Brasil that es-
tablishes the anti-inflammatory properties of a steroidal 
saponin extracted from its leaves(12). In the present study 
we show the results of a different subspecie, that despite 
being reported to grow up in our country, it contains Δ5 sa-
ponins(13), unlike those studies from Brazilian researchers 
who described a 5α spirostan saponin with carbonil group 
attached at the C-12 position. 
The previous evidences do not show enough experimen-
tal studies about the anti-inflammatory activity in vivo of 
steroidal saponins from a butanolic fraction of leaves of 
Agave brittoniana subsp. brachypus. Thus, the aim of the 
present study was to assess the anti-inflammatory effect of 
a saponin-enriched fraction from Agave brittoniana subsp. 
brachypus (Trel.) A. Álvarez, (Asparagaceae) in experimental 
animals.
METHODS
A phytochemical study of saponin-enriched fraction from 
A. brittoniana leaves was carried out to confirm the presence 
of metabolites with pharmacological potential. The butan-
olic extract obtained was evaluated in acute and chronic 
experimental models of inflammation.
The A. brittoniana leaves were collected in the morning 
hours in Cubanacan protected area, nearby to the Santa 
Clara city. The voucher specimen was identified in the Bo-
tanic Garden of UCLV (HPVC # 5445). Healthy leaves were 
selected, without mechanical, chemical or microbiological 
detectable damage.
Drying and milling
To facilitate drying, the collected plant material was finely 
cut. The plant was dried for 7 days at 40 °C in oven (Binder, 
Germany). The dried material was milled on a cutting mill-
er (IKA-MF 10B, Germany) at 3000 rpm. The product was 
sieved through a 3 mm internal diameter sieve.
Organoleptic properties and numerical indexes of the 
dry drug
Smell and color of the dry drug were recorded. The nu-
merical indexes, total ash and moisture residual content 
were determined to the dried and milled material, (Public 
Health Branch Standard 309: NRSP 309). The determination 
of moisture residual content was made by the gravimetric 
method(14).
Obtaining saponins from crud extract
The extractive process described by Guerra and several re-
searchers in order to obtain saponins-enriched extracts was 
done.(15-17) First, a hydroalcoholic extract was obtained: 300 
g of the dry and milled plant material was macerated with 1 
L of 70% ethanol and protected from light. The menstruum 
was reconstituted in alternate days until total discoloration 
of the mixture. Then, a dark green mixture was obtained 
by rotoevaporation at 40 °C (RotoevaporadorIKA® RV 10 
basic).
Afterwards, 50 g of the hydroalcoholic extract was resus-
pended in one portion of water and diluted in 180 mL of 
distilled water. The mixture was placed in a separatory 
funnel, adding 180 ml of n-butanol. It was previously sat-
urated with water, and the extractions were made every 
24 hours for three days. Two fractions were obtained, one 
organic, containing the crude saponins, and another aque-
ous. Finally, the n-butanolic fraction was rotoevaporated 
toward total dryness.
Phytochemical screening
To corroborate the composition of the n-butanolic fraction, 
phytochemical screening was carried out following the 
technique described by Miranda and Cuéllar(18).
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Acute model of carrageenan-induced rat paw edema
It was carried out according to the method described in 
CYTED(19). Male Sprague-Dawley rats of initial weight be-
tween 180-200 g were used. Food was removed three hours 
before administration. Doses of 25, 50 and 100 mg/kg of 
the n-butanolic fraction or saponin-enriched fraction were 
applied orally. The control group received only the vehi-
cle (distilled water) and the positive control received in-
domethacin as an anti-inflammatory agent (7 mg/kg p.v.). 
One hour after the administration of the product, 0.1 mL of 
a solution of carrageenan (1%) in physiological saline was 
administered into the plantar aponeurosis of the right hind 
paw of each rat. The thickness of the leg was measured 
with a tape measure before inducing the edema and at one, 
three, four and five hours after injection with carrageenan.
The inhibition percentage of the inflammatory reaction of 
γ-carrageenan was calculated at one, three, four and five 
hours of the injection, using the following formula:
Chronic model of cotton pellet-induced granuloma
The technique described by Sheth and updated by other re-
searchers was used (20, 21). Prior to the experiment, the cotton 
discs were weighed (average weight 16 ± 2 mg) and steril-
ized in an autoclave. The animals were anesthetized with 
ketamine hydrochloride (50mg/kg). Sterilized cotton pellet 
were surgically inserted in the axillary region of each rat 
through a single needle incision. 
The next day group I (negative control) received distilled 
water (10 mL/kg). Groups II, III and IV received doses of 
25, 50 and 100 mg/kg of the n-butanolic fraction, respec-
tively. Group V (positive control) received solution of indo-
methacin (5 mg/kg). This oral administration was repeated 
for seven days at a rate of 10 mL/kg. On the eighth day, the 
animals were sacrificed by ether overdose followed by cer-
vical dislocation, taking into account the Good Laboratory 
Practices(22).
The granulomas formed were extracted and weighed on an 
analytical balance. Then, they were dried in the oven for 
two hours at 60 °C and weighed again to determine their 
dry weight, which corresponds to the amount of fibrogran-
ulomatous tissue formed in the chronic stage of inflamma-
tion. 
The corresponding inhibition percentage was determined 
according to the following formula:
Statistical analysis
The data was processed by the statistical package SPSS 
for Windows Version 20.0. Mean and standard deviation 
of the parameters evaluated were determined. Differenc-
es between the parameters obtained in each experimental 
group were made using the ANOVA and t-student para-
metric test and the non-parametric tests of Kruskal Wallis 




The qualitative evaluation of the phytochemical composi-
tion of the n-butanolic fraction is show in Table 1. 









Triterpens and Steroids Liebermann-Burchard +
Quinones Borntrager -
Coumarins Baljat -
Essentials Oils and Fats Sudan III -
Reducer sugars Fehling +++
Saponins Espuma +++
Phenols and Tanins Iron Chloride (III) -
Aminoacids and Amines Nihidrina -
Flavonoids Shinoda -
Glycosides Molish -
Cardiotonic Glycosides Kedde-Raymond -
+Low +++ High
These results demonstrate the success of the followed pro-
cedure to extract steroidal saponins to a butanolic fraction 
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starting from a hydroalcoholic extract of A. brittoniana 
leaves.
Acute model of carrageenan-induced rat paw edema
Figure 1 illustrates the evolution of the paw´s thickness 
during five hours. As can be seen, all the treated groups had 
less value in the indicator paw´s thickness than the control 
without treatment. A dose-dependent effect, with an area 
under the curve less than indomethacin in the group of 100 
mg / kg butanolic fraction is also found.
Figure 1. Values of the paw´s thickness (VPT).
The average paw´s thickness and % INHAP calculated for 
each group at different time are showed in Table 2.
Table 2. Anti-inflammation effect in acute model of carrageen-
an-induced rat paw edema
Average Paw´s Thickness (mm)







































45.00±10.49a 46.67±10.33a 41.67±7.53a 40.00±6.32a
The statistical analysis of the paw thickness variation of 
treated animals showed significant differences from the 
first hour after the administration of the inflammatory in-
ductor (Kruskal Wallis, p = 0.01). All groups of the n-buta-
nolic fraction showed lower values of paw´s thickness than 
those observed in the control group from the first hour. 
The anti-inflammatory effect of indomethacin was ob-
served afther three hours. All groups of saponin-enriched 
fraction behaved similarly to this anti-inflammatory drug 
(Mann-Whitney, p > 0.05). At four hours anti-inflammatory 
effect of the saponin-enriched fraction was observed, high-
lighting that 100 mg/kg dose presented higher inhibition 
than the indomethacin. The % INHAP of medium and high 
doses of n-butanolic fraction had kept similar values to the 
indomethacin group, at five hours.
Chronic model of cotton pellet-induced granuloma
Table 3 shows the fibro granulomatose content and the percentage 
of inhibition of experimental groups. 






nBF25 9.58 ± 3.32a 53.72
nBF50 11.57 ± 1.71a 45.76
nBF100 8.96 ± 4.21b 56.40
INDOM 14.33 ± 4.06a 53.66
CONTROL 22.7 ± 4.98c -
nBF: n-butanolic fraction in doses of 25, 50 and 100mg/kg, IN-
DOM: indomethacin
Different font means statistical differences in the same column  
(p < 0.05, t-student Test)
The one-way ANOVA test indicated significant differenc-
es in the weight of the fibrogranulose content. The group 
without treatment presented values of 22.7 ± 4.98 mg of 
fibrogranulose content, significantly higher than all the 
treated groups (p > 0.05, t student). The highest dose of 
n-butanolic fraction registered even lower values than the 
indomethacin group, while the rest of doses presented sta-
tistically similar values to this group (p = 0.05, t student). 
The percentage of the inhibitory inflammation, according 
to the dry content, showed values very similar to the indo-
methacin, with a slightly higher value in the group of 100 
mg/kg of saponin-enriched fraction. 
DISCUSSION
The saponins from crude extract obtained with low con-
tamination of other metabolites coincide with reports of 
The reported values between parentheses represent the % INHAP. 
nBF: n-butanolic fraction in doses of 25, 50 and 100 mg/kg, IN-
DOM: indomethacin
Different font means statistical differences in the same column (p 
< 0.05, Man Whitney Test)
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extraction of saponins in other species following the same 
extraction protocol(23-25). Former studies about A. brittoniana 
carried out by Guerra and collaborators stated that the best 
method to obtain saponin-enriched leaves extracts from 
this species is by using serial extractions of ethanol first 
and butanol through a separatory funnel later, as well as 
we used in this study.(15,16)
The steroidal saponins, metabolites of interest in A. britto-
niana, should share, from their chemical structure, pharma-
cological properties similar to corticosteroids. These endog-
enous molecules have an anti-inflammatory effect due to 
their ability to stabilize the lysosomal membrane, to reduce 
capillary permeability and the releasing of bradykinin and 
histamine. The corticosteroids stimulate the synthesis of li-
pocortins, inhibitory proteins blocking the phospholipase 
A2 synthesis and then affecting eicosanoid synthesis(26,27).
Previous studies indicate that one hour after the adminis-
tration of γ-carrageenan; histamine and serotonin have a 
major role as mediators. Approximately, at two hours the 
kinins intervene. Between three and four hours after in-
duction, the maximum vascular response coincides with 
the phase mediated by the prostaglandins PGE1, PGE2 and 
PGF2
(28,29).
The data suggest that the saponins extracted from the plant 
exert their activity by inhibiting the release of the first me-
diators. This situation illustrates how in the acute model of 
carrageenan, a decrease in inflammation with respect to the 
negative control group and indomethacin is observed from 
the first hour. Several studies relate that saponins could 
contribute to the membrane´s stabilization, in this phase, 
by decreasing capillary permeability(30,31).
After three hours the activity increases, which is seen in 
the abrupt fall of the inflammation values (Figure 1). In 
this phase, the production of prostaglandins is activated. 
As it has been already indicated, the structural similarity 
of the steroidal saponins with the endogenous steroids al-
lows assuming the inhibition of the eicosanoid synthesis, 
preventing the release of inflammatory prostaglandins. In-
domethacin, a drug inhibiting the cyclooxygenase and the 
synthesis of prostaglandins, has its greatest activity after 
three hours, which coincides with other authors(32).
An increase in the recruitment of macrophages, lympho-
cytes and different substances closely related to the im-
mune response, can be observed in the proliferative phase 
of chronic model of cotton pellet-induced granuloma(33). 
Steroidal saponins, as corticosteroids, could reduce the 
number of inflammatory cells, including eosinophils, T 
lymphocytes, mast cells and dendritic cells, in different tis-
sues. Then, these secondary metabolites could decrease the 
size of the granuloma by suppressing the growth of colla-
gen fiber(7). 
Saponins, such as escin, have an anti-inflammatory effect 
in chronic model of cotton pellet-induced granuloma, pos-
sibly by inhibition of signal molecules related to the glu-
cocorticoid receptor(34). Agave americana species have been 
studied in both acute and chronic inflammation models. In 
the second, the presence of saponins is responsible for the 
decrease in granuloma´s dry weight, which means their an-
ti-inflammatory activity in this model(35).
Finally, an aspect to highlight is the known structural com-
position of the saponins present in A. brittoniana. Their 
aglycone coincides with sapogeninas such as diosgenin 
and yuccagenin(13,16,17). Several studies have shown that di-
osgenin inhibits the production of several proinflammato-
ry interleukines, as well as the generation of free radicals, 
decreasing the macrophages’ recruitment(36). Saponins have 
a non-negligible intestinal metabolism, which allows the 
steroidal ring to be absorbed and passed into the systemic 
circulation where it could reach the target tissues(37). Yuc-
cagenin, a major sapogenin in this species, is like diosgen-
in with an additional hydroxyl group en position two(38). 
For that reason, it is necessary to conduct other studies to 
evaluate the anti-inflammatory contribution of yuccagenin 
present in A. brittoniana. 
The results allow us to conclude that the saponin-enriched 
butanolic fraction from the hydroalcoholic extract of Aga-
ve brittoniana could have the major contribution of anti-in-
flammatory effect of this specie, comparable to indometha-
cin in acute and chronic models. Subsequent research could 
indicate which saponins or sapogenins found in the plant 
are the ones with the greatest contribution to this activity.
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